|
| 33495398 | Correction for McMullen et al., "Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy". | Mol Cell Biol | 2021 |
| 28111276 | Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes. | Stem Cell Reports | 2017 |
| 22228770 | Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy. | J Biol Chem | 2012 |
| 20237330 | PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. | Arterioscler Thromb Vasc Biol | 2010 |
| 20847309 | Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress. | Circ Res | 2010 |
| 19122165 | Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function. | Am J Physiol Heart Circ Physiol | 2009 |
| 20082935 | Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. | J Am Coll Cardiol | 2009 |
| 19679877 | Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. | Am J Pathol | 2009 |
| 19544447 | Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. | Stem Cells | 2009 |
| 18267957 | Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. | Cardiovasc Res | 2008 |
| 18688045 | Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning. | Circ Res | 2008 |
| 17250822 | Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. | Dev Biol | 2007 |
| 17908558 | A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. | Cell Metab | 2007 |
| 17904155 | Resistin, an adipocytokine, offers protection against acute myocardial infarction. | J Mol Cell Cardiol | 2007 |
| 17604724 | A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. | Cell | 2007 |
| 17660828 | Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. | Nat Med | 2007 |
| 17202264 | Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. | Proc Natl Acad Sci U S A | 2007 |
| 16469952 | Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. | Arterioscler Thromb Vasc Biol | 2006 |
| 17019808 | Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. | Novartis Found Symp | 2006 |
| 16762803 | Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. | J Card Fail | 2006 |
| 16716207 | Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses. | BMC Genet | 2006 |
| 16983087 | Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. | Proc Natl Acad Sci U S A | 2006 |
| 16914500 | Development of heart valves requires Gata4 expression in endothelial-derived cells. | Development | 2006 |
| 15673394 | Absence of Msx2 does not affect cardiac conduction or rescue conduction defects associated with Nkx2-5 mutation. | J Cardiovasc Electrophysiol | 2005 |
| 16227599 | Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. | Mol Cell Biol | 2005 |
| 16298682 | Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo. | Free Radic Biol Med | 2005 |
| 15902305 | Morphogenesis of the right ventricle requires myocardial expression of Gata4. | J Clin Invest | 2005 |
| 15850572 | Dysregulation of connexins and inactivation of NFATc1 in the cardiovascular system of Nkx2-5 null mutants. | J Mol Cell Cardiol | 2005 |
| 15972800 | Haploinsufficiency of the cardiac transcription factor Nkx2-5 variably affects the expression of putative target genes. | FASEB J | 2005 |
| 15623566 | Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. | Physiol Genomics | 2005 |
| 14597618 | The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. | J Biol Chem | 2004 |
| 15226426 | Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. | Mol Cell Biol | 2004 |
| 15184287 | Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. | Circulation | 2004 |
| 15464586 | GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. | Dev Biol | 2004 |
| 15368343 | Function follows form: cardiac conduction system defects in Nkx2-5 mutation. | Anat Rec A Discov Mol Cell Evol Biol | 2004 |
| 15368344 | Transcriptional regulation of cardiac conduction system development: 2004 FASEB cardiac conduction system minimeeting, Washington, DC. | Anat Rec A Discov Mol Cell Evol Biol | 2004 |
| 15001440 | Alterations in apoptosis regulatory factors during hypertrophy and heart failure. | Am J Physiol Heart Circ Physiol | 2004 |
| 15085192 | Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. | J Clin Invest | 2004 |
| 14679301 | Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. | Physiol Genomics | 2004 |
| 12754203 | Csm, a cardiac-specific isoform of the RNA helicase Mov10l1, is regulated by Nkx2.5 in embryonic heart. | J Biol Chem | 2003 |
| 14507992 | Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. | Proc Natl Acad Sci U S A | 2003 |
| 12956333 | Cardiac conduction and arrhythmia: insights from Nkx2.5 mutations in mouse and humans. | Novartis Found Symp | 2003 |
| 14595838 | Cardiac electrophysiological phenotypes in postnatal expression of Nkx2.5 transgenic mice. | Genesis | 2003 |
| 14551244 | Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos. | Circ Res | 2003 |
| 14645532 | Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis. | Mol Cell Biol | 2003 |
| 12663489 | NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. | Circ Res | 2003 |
| 12676539 | Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. | J Mol Cell Cardiol | 2003 |
| 12668503 | Rapamycin attenuates load-induced cardiac hypertrophy in mice. | Circulation | 2003 |
| 12727144 | Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. | Trends Mol Med | 2003 |
| 11809903 | Elucidating the molecular and genetic interactions responsible for congenital heart disease. | Pediatr Res | 2002 |